| 股東 | |||||
|---|---|---|---|---|---|
Zhejiang Lionco Pharmaceutical Co., Ltd. | 48.28% | 3.40 億 | 0.00% | +0 | 31/03/2026 |
Ling Ping TaoChairman of the Board | 6.84% | 4,815.72 萬 | 0.00% | +0 | 31/03/2026 |
Wen Nan WangFormer Director | 2.99% | 2,105.86 萬 | 0.00% | +0 | 31/03/2026 |
Xiao Gang TaoGM & Director | 2.29% | 1,612.88 萬 | 0.00% | +0 | 31/03/2026 |
Chong Zhu | 0.65% | 458.86 萬 | 0.00% | +0 | 30/06/2025 |
Guozhong Shen | 0.54% | 381.30 萬 | 0.00% | +0 | 31/12/2024 |
The Goldman Sachs Group, Inc. | 0.52% | 366.09 萬 | -- | +366.09 萬 | 31/03/2026 |
Ling Gang TaoFormer GM & Director | 0.49% | 347.00 萬 | 0.00% | +0 | 31/03/2026 |
Lion Fund Management Co. Ltd. | 0.49% | 343.15 萬 | -- | +343.15 萬 | 31/03/2026 |
CCB Principal Asset Management Co., Ltd. | 0.40% | 279.16 萬 | -- | +279.16 萬 | 31/03/2026 |
Shanghai Danyin Investment Management Center (Limited Partnership) | 0.36% | 253.30 萬 | 0.00% | +0 | 30/09/2025 |
Jun Ke ZhangAccounting Supervisor & Financial Director | 0.02% | 11.94 萬 | 0.00% | +0 | 31/12/2025 |
Zhonghai Fund Management Co., Ltd. | <0.01% | 3.24 萬 | 0.00% | +0 | 31/12/2025 |
Rongtong Fund Management Co. Ltd. | <0.01% | 1.27 萬 | 0.00% | +0 | 31/12/2025 |
China Asset Management Co. Ltd. | <0.01% | 100.00 | 0.00% | +0 | 31/12/2025 |
